Answer
Fenofibrate enhances oral anticoagulant effects and may increase bleeding risk; the anticoagulant dose should be reduced by about one-third when fenofibrate starts, then gradually adjusted if necessary according to INR monitoring.
Sources for this answer
- Lipantil Micro 67Viatris (formerly Mylan or Upjohn) · emc · SmPC §4.5 Interaction with other medicinal products · Version 30Document updated
Sources checked